Literature DB >> 15863436

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Rachel A Whitmer1, Erica P Gunderson, Elizabeth Barrett-Connor, Charles P Quesenberry, Kristine Yaffe.   

Abstract

OBJECTIVE: To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life.
DESIGN: Analysis of prospective data from a multiethnic population based cohort.
SETTING: Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation. PARTICIPANTS: 10,276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994. MAIN OUTCOME MEASURES: Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease.
RESULTS: Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index > or = 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04).
CONCLUSIONS: Obesity in middle age increases the risk of future dementia independently of comorbid conditions.

Entities:  

Mesh:

Year:  2005        PMID: 15863436      PMCID: PMC558283          DOI: 10.1136/bmj.38446.466238.E0

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  36 in total

1.  Obesity is a chronic, relapsing neurochemical disease.

Authors:  G A Bray
Journal:  Int J Obes Relat Metab Disord       Date:  2004-01

2.  Weight loss precedes Alzheimer's disease symptoms: a case study.

Authors:  J Knittweis
Journal:  J Am Geriatr Soc       Date:  1998-04       Impact factor: 5.562

3.  Weight loss in people with Alzheimer's disease: a prospective population based analysis.

Authors:  D Cronin-Stubbs; L A Beckett; P A Scherr; T S Field; M J Chown; D M Pilgrim; D A Bennett; D A Evans
Journal:  BMJ       Date:  1997-01-18

4.  The multitest laboratory in health care.

Authors:  M F Collen; L F Davis
Journal:  J Occup Med       Date:  1969-07

5.  Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.

Authors:  A J Karter; E J Mayer-Davis; J V Selby; R B D'Agostino; S M Haffner; P Sholinsky; R Bergman; M F Saad; R F Hamman
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

6.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women.

Authors:  K Yaffe; T Blackwell; A M Kanaya; N Davidowitz; E Barrett-Connor; K Krueger
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

7.  An 18-year follow-up of overweight and risk of Alzheimer disease.

Authors:  Deborah Gustafson; Elisabet Rothenberg; Kaj Blennow; Bertil Steen; Ingmar Skoog
Journal:  Arch Intern Med       Date:  2003-07-14

8.  Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women.

Authors:  Ingrid Lofgren; Kristin Herron; Tosca Zern; Kristy West; Madhu Patalay; Neil S Shachter; Sung I Koo; Maria Luz Fernandez
Journal:  J Nutr       Date:  2004-05       Impact factor: 4.798

Review 9.  Human body composition and the epidemiology of chronic disease.

Authors:  R N Baumgartner; S B Heymsfield; A F Roche
Journal:  Obes Res       Date:  1995-01

10.  Is obesity an inflammatory disease?

Authors:  Eduardo J B Ramos; Yuan Xu; Irina Romanova; Frank Middleton; Chung Chen; Robert Quinn; Akio Inui; Undurti Das; Michael M Meguid
Journal:  Surgery       Date:  2003-08       Impact factor: 3.982

View more
  343 in total

Review 1.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

2.  Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study.

Authors:  Adesola Ogunniyi; Su Gao; Frederick W Unverzagt; Olusegun Baiyewu; Oyewusi Gureje; James Tat Nguyen; Valerie Smith-Gamble; Jill R Murrell; Ann M Hake; Kathleen S Hall; Hugh C Hendrie
Journal:  Int Psychogeriatr       Date:  2010-08-25       Impact factor: 3.878

3.  Coordination, childhood weight gain and obesity.

Authors:  Scott M Montgomery
Journal:  CMAJ       Date:  2010-06-28       Impact factor: 8.262

4.  Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure.

Authors:  David Zade; Alexa Beiser; Regina McGlinchey; Rhoda Au; Sudha Seshadri; Carole Palumbo; Philip A Wolf; Charles DeCarli; William Milberg
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-08-10       Impact factor: 2.136

Review 5.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 6.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

8.  Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

9.  Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.

Authors:  Tzu-Ying Chen; Mario G Ferruzzi; Qing-Li Wu; James E Simon; Stephen T Talcott; Jun Wang; Lap Ho; George Todd; Bruce Cooper; Giulio M Pasinetti; Elsa M Janle
Journal:  Mol Nutr Food Res       Date:  2017-08-14       Impact factor: 5.914

10.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Authors:  Wolfgang Lieb; Alexa S Beiser; Ramachandran S Vasan; Zaldy S Tan; Rhoda Au; Tamara B Harris; Ronenn Roubenoff; Sanford Auerbach; Charles DeCarli; Philip A Wolf; Sudha Seshadri
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.